Frankfurt, Germany

Clarient Gmbh


USPTO Granted Patents = 13

% Expired Patents = 69.2

Trademarks = 3

Forward Citations = 577

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Jose De La Torre-Bueno (3 out of 25 patents)

silverMedal Gina Marie McLaren (3 out of 11 patents)

bronzeMedal James W Douglass (2 out of 14 patents)

4.  Jose deLa Torre Bueno (2 out of 2 patents)

5.  Thomas J Riding (2 out of 10 patents)

6.  James E Ring (2 out of 9 patents)

7.  William J Decker (2 out of 9 patents)

8.  Bob Ellis (2 out of 5 patents)

9.  Roman Morschhäuser (1 out of 33 patents)

10.  Daniel Decker (1 out of 12 patents)

11.  Jack Zeineh (1 out of 13 patents)

12.  Frank Anthony Palmieri, Jr (1 out of 19 patents)

13.  Jeffrey Beckstead (1 out of 11 patents)

14.  Robert T Ellis (1 out of 10 patents)

15.  Matthias Löffler (1 out of 31 patents)


13 patents:

Company Overview
Clarient GmbH, based in Frankfurt, Germany, specializes in the development and manufacturing of innovative solutions in the field of medical technology. The company focuses on enhancing diagnostic processes and improving patient outcomes through advanced technologies. With a commitment to research and development, Clarient is dedicated to pushing the boundaries of medical diagnostics, ensuring that healthcare providers have access to cutting-edge tools and insights for effective patient care.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

13 Patents

#63 in Frankfurt

#3,085 in Germany

#45,081 in the World

Frankfurt, DE
Frankfurt, Germany
Forward Citations = 577

22 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Clarient Gmbh. Retrieved from https://idiyas.com/company/clarient

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…